Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Rosuvastatin 20 mg vs Crestor in Healthy Adults
NCT02767310Phase 1Completed
- Sponsor
- Verisfield
- Start
- May 2016
- Primary completion
- Jun 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of rosuvastatin in hypercholesterolemia (2 arms), sponsored by Verisfield. Primary endpoints: Area under the plasma concentration from zero to time t and Maximum plasma concentration. Started May 2016; status: completed.
02
Drugs
rosuvastatin
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT02767310.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02767310.